Skip to content
45

ass 100 tabletten

Skip it

Soft demand (-13.6% this quarter) — this niche doesn't clear our bar today.

Market size 26Growth 18Conversion 98Competition 32Returns 100Price range 47Avg price 30Brand share 32Review moat 82Quality gap 22

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Incredible16.8%

search→purchase rate — share of searches ending in a sale

Review moat

Great366.8

avg incumbent reviews — the moat a new listing must climb

Price range

Okay€4.75–€23.91

cheapest to priciest tracked listing — scored on the share inside $15–$100

Competition

Okay66%

top-5 click share — leaders hold, buyers still browse

Brand share

Okay86%

top-5 brand share — brands hold most of the demand

Avg price

Okay€9.61

avg listing price — sweet spot $15–$100

Market size

Okay€107K

€107K/yr · 66K searches

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Growth

Bad-13.6%

90-day search growth — must beat 0% to launch

Competition

The top 5 products take 66% of clicks — established leaders, but buyers still shop beyond them.

Brands

9 falling

Sellers

25

Top-5 brand share

86%

Open market

9%

  • Aspirin23%
  • ratiopharm23%
  • Bayer20%
  • apo-discounter.de12%
  • vitenda7%
  • Faar Apo5%
  • Open — no brand owns it (3 brands, 9%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%€11K20%€21K30%€32K40%€43K1101001K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 15 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — -13.6% search growth over the last 90 days.
10K6KSpike '24Black Friday '24Holiday '24Spike '25Spike '26SepDecMarJunAugNovMarMay

Peak months: Oct, Nov · busiest ÷ quietest = 2.5×